His Kidney Drug Just Won FDA Approval After Cutting a Key Disease Marker by 43%. One $74,730 Infusion Could Leave Him Owing Nearly $15,000 Under Original Medicare
Gerelyn Terzo is the author of dividend investing handbook "Dividend Investing Strategies: How to Have Your Cake & Eat It Too." A veteran financial journalist, she covers agri-finance for outlets like Global AgInvesting and the broader stock market and personal finance for 24/7 Wall Street. She began at CNBC and…